Is platelet transfusion the solution to reverse platelet inhibition in patients on triple antiplatelet therapy?

Thromb Res. 2015 Dec;136(6):1057-8. doi: 10.1016/j.thromres.2015.10.040. Epub 2015 Oct 30.

Author

Marie Lordkipanidzé¹

Affiliation

¹ Faculté de pharmacie, Université de Montréal, C.P. 6128, succ. Centre-ville, Montréal, Québec H3C 3J7, Canada; Research Center, Montreal Heart Institute, 5000 rue Bélanger, Montréal, Québec H1T 1C8, Canada. Electronic address: marie.lordkipanidze@umontreal.ca.

PMID: 26548621
DOI: 10.1016/j.thromres.2015.10.040

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aspirin / therapeutic use
Blood Platelets / drug effects
Drug Therapy, Combination
Humans
Platelet Aggregation / drug effects
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Transfusion*
Ticlopidine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Ticlopidine
Aspirin